Trial · NCT00829296
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Central Systolic Blood Pressure (SBP) | Nebivolol | Aortic Systolic Blood Pressure at Baseline | 125.3 | Standard Deviation 8.0 | mmHg |
| Change in Central Systolic Blood Pressure (SBP) | Metoprolol | Aortic Systolic Blood Pressure at Baseline | 127.8 | Standard Deviation 8.8 | mmHg |
| Change in Central Systolic Blood Pressure (SBP) | Nebivolol | Aortic Systolic Blood Pressure at 26 Weeks | 121.6 | Standard Deviation 8.2 | mmHg |
| Change in Central Systolic Blood Pressure (SBP) | Metoprolol | Aortic Systolic Blood Pressure at 26 Weeks | 123.8 | Standard Deviation 11.1 | mmHg |
| Change in Pulse Wave Velocity (PWV) | Nebivolol | Pulse wave velocity at Baseline | 6.48 | Standard Deviation 0.8 | m/s |
| Change in Pulse Wave Velocity (PWV) | Metoprolol | Pulse wave velocity at Baseline | 6.52 | Standard Deviation 1.2 | m/s |
| Change in Pulse Wave Velocity (PWV) | Nebivolol | Pulse wave velocity at 26 Weeks | 6.3 | Standard Deviation 0.9 | m/s |
| Change in Pulse Wave Velocity (PWV) | Metoprolol | Pulse wave velocity at 26 Weeks | 6.4 | Standard Deviation 1.3 | m/s |
| Change in Augmentation Index | Nebivolol | Augmentation index at Baseline | 22.0 | Standard Deviation 7.1 | percent (%) |
| Change in Augmentation Index | Metoprolol | Augmentation index at Baseline | 26.2 | Standard Deviation 8.3 | percent (%) |
| Change in Augmentation Index | Nebivolol | Augmentation index at 26 Weeks | 22.1 | Standard Deviation 7.4 | percent (%) |
| Change in Augmentation Index | Metoprolol | Augmentation index at 26 Weeks | 24.6 | Standard Deviation 6.7 | percent (%) |
| Change in Pulse Pressure Amplification | Nebivolol | Pulse pressure amplification at Baseline | 0.77 | Standard Deviation 0.08 | ratio |
| Change in Pulse Pressure Amplification | Metoprolol | Pulse pressure amplification at Baseline | 0.79 | Standard Deviation 0.09 | ratio |
| Change in Pulse Pressure Amplification | Nebivolol | Pulse pressure amplification at 26 Weeks | 0.83 | Standard Deviation 0.09 | ratio |
| Change in Pulse Pressure Amplification | Metoprolol | Pulse pressure amplification at 26 Weeks | 0.85 | Standard Deviation 0.12 | ratio |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00829296/results